What Is TB-500?
Thymosin Beta-4 is a 43-amino-acid protein that occurs naturally in most human tissue. It's found in particularly high concentrations in wound fluid and platelets — places where tissue repair is actively occurring. TB-500 is a synthetic fragment of this protein, derived from the actin-binding region (the sequence LKKTETQ), which appears to be responsible for the bulk of its biological activity.
It is not FDA-approved for any indication. Available in Tennessee from licensed compounding pharmacies with physician oversight. The research base is primarily preclinical — animal studies and in vitro work — with some early human trial data on the full thymosin beta-4 protein in cardiac injury contexts.
Mechanism of Action
TB-500's effects appear to work through several overlapping pathways:
- Actin sequestration: TB-500 binds to G-actin and regulates actin polymerization, which is critical for cell migration and wound healing
- Angiogenesis: Promotes formation of new blood vessels, improving circulation to injured tissue
- Anti-inflammatory: Downregulates several pro-inflammatory cytokines at injury sites
- Stem cell recruitment: Preclinical data suggests TB-4 mobilizes stem cells from bone marrow to areas of injury
Most mechanism data comes from animal models. Human clinical evidence is limited. For educational purposes only — consult your physician for treatment decisions.
Who Uses TB-500
Tennessee patients pursuing TB-500 are almost always dealing with a specific injury. This is not a general wellness peptide like sermorelin. Common profiles:
- Runners with chronic Achilles or patellar tendinopathy
- CrossFit athletes with rotator cuff issues or elbow tendinitis
- Post-surgical patients who want to accelerate healing after orthopedic procedures
- Active adults in their 40s–60s with soft tissue injuries that have not responded to physical therapy alone
- Patients who have used BPC-157 and want a complementary compound for broader tissue repair
Dosing Protocol
Loading Phase
2–2.5mg twice weekly for 4–6 weeks. This is the standard protocol for acute or subacute injuries where the goal is accelerated tissue repair. Subcutaneous or intramuscular injection.
Maintenance Phase
2–2.5mg once weekly. Used after the loading phase for ongoing support, or in patients with chronic injury patterns who benefit from sustained low-level TB-500 activity.
Vials are lyophilized powder. They must be reconstituted with bacteriostatic water before injection. Your pharmacy will provide reconstitution instructions and supplies.
TB-500 vs. BPC-157
Both are injury-recovery peptides. They differ in mechanism and primary application.
| TB-500 | BPC-157 | |
|---|---|---|
| Primary strength | Muscle & broad soft tissue | Tendon-to-bone & gut |
| Anti-inflammatory | Strong systemic effect | Localized to injury site |
| Admin route | Injection only | Injection or oral capsule |
| Cost | $80–150/vial | $150–250/month |
Many patients use both simultaneously. Your physician can advise on combination protocols.
Safety & Side Effects
Human safety data on TB-500 specifically is limited. Based on preclinical studies and clinical use experience, it appears well-tolerated at standard doses. Reported side effects are uncommon and typically mild:
- Injection site reactions (redness, mild swelling)
- Transient fatigue or lethargy following injection
- Head rush or lightheadedness in some patients
Due to its angiogenic and cell-proliferative effects, TB-500 is not recommended for patients with a history of cancer or active malignancy. Disclose your full medical history to your prescribing physician.
Cost in Tennessee
TB-500 from a Tennessee-licensed compounding pharmacy runs $80–150 per vial. A standard loading protocol (4–6 weeks at twice-weekly dosing) requires 8–12 vials. Consultation fees are $99–199. See our full cost guide.